Yıl: 2010 Cilt: 34 Sayı: 4 Sayfa Aralığı: 517 - 527 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties

Öz:
2-(4-Amino-3-(4-chlorophenyl)-5-oxo-4,5–dihydro-1H -1,2,4-triazol-1-yl)-N' -[(2,6-dihalogenophenyl)- methylene]acetohydrazides (3a,b) was obtained via the formation of 2-(4-amino-3-(4-chlorophenyl)-5-oxo- 4,5-dihydro-1H -1,2,4-triazol-1-yl)acetohydrazide (2), which was obtained starting from 4-amino-5-(4-chlorophenyl)- 2,4-dihydro-3H -1,2,4-triazol-3-one (1) in 2 steps. 2-{[4-amino-3-(4-chlorophenyl)-5-oxo-4,5–dihydro- 1H-1,2,4-triazol-1-yl]acetyl}-N-phenylhydra-zine carbothioamide (4), which was prepared starting from 2, was converted to the corresponding 1,3,4-thiadiazole derivative (5) in acidic media. Moreover, the basic treatment of 4 resulted in the formation of 4-amino-5-(4-chlorophenyl)-2-[(4-phenyl-5-thioxo-4,5-dihydro- 1H-1,2,4-triazol-3-yl)methyl]-2,4-dihydro-3H-1,2,4-triazol-3-one (7). The reactions of compounds 5 and 7 with methyl iodide in the presence of sodium ethoxide afforded the corresponding N-methyl (6) and Smethyl (8) derivatives, respectively. The synthesis of Mannich bases (10a and 10b) was performed from the reaction of 7 with morpholine or piperazine in the presence of formaldehyde. All the newly synthesized compounds were screened for their antimicrobial activity. The antimicrobial activity study revealed that compounds 3a, 3b, and 5 showed good antimicrobial activities against the test microorganisms as compared with ampicillin.
Anahtar Kelime:

Konular: Mühendislik, Kimya
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Bekhit, A. A.; El-Sayed, O. A.; Aboulmagd, E.; Park, J. Y. Eur. J. Med. Chem. 2004, 39, 249-255.
  • 2. Farghaly, A. M.; Bekhit, A. A.; Park, J. Y. Arch. Pharm. Pharm. Med. Chem. 2000, 333, 53-57.
  • 3. Almajan, G. L.; Barbucenau, S. F.; Almajan, E. R.; Draghici, C.; Saramet, G. Eur. J. Med. Chem. 2009, 44, 3083-3089.
  • 4. Labanauskas, L.; Udrenaite, E.; Gaidelis, P.; Brukstus, A. Il Farmaco 2004, 59, 255-259.
  • 5. Bayrak, H.; Demirbas, A., Alpay-Karaoglu, S.; Demirbas, N. Eur. J. Med. Chem. 2009, 44, 1057-1066.
  • 6. Chen, M. D.; Lu, S. J.; Yuang, G. P.; Yang, S. Y.; Du, X. L. Heterocyclic Comm. 2000, 6, 421-426.
  • 7. Holla, B. S.; Mahalingan, M.; Karthikeyan, M. S., Poojary, B.; Akberali, P. M.; Kumari, N. S. Eur, J. Med. Chem. 2005, 40, 1173-1178.
  • 8. Liu, S.; Qian, X.; Song, G.; Chen, J.; Chen, W. J. Florine Chem. 2000, 105, 111-115.
  • 9. Demirbas, N.; Karaoglu, S. A.; Demirbas, A.; Sancak, K. Eur. J. Med. Chem. 2004, 39, 793-804.
  • 10. Demirbas, N.; Ugurluoglu, R.; Demirbas, A. Bioorg. Med. Chem. 2002, 10, 3717-3723.
  • 11. Demirbas, A.; Sahin, D.; Demirbas, N.; Alpay-Karaoglu, S. Eur. J. Med. Chem. 2009, in press.
  • 12. Demirbas, N.; Demirbas, A.; Alpay-Karaoğlu, S.; Russian J. Bioorg. Chem. 2005, 31, 430-440.
  • 13. Yu, L. T.; Ho, M. T.; Chang, C. Y.; Yang, T. K. Tetrahedron: Asim. 2007, 18, 949-962.
  • 14. Gupta, A.; Unadkat, J. D.; Mao, Q. J. Pharm. Sci. 2007, 96, 3226-3235.
  • 15. Schiller, S. D.; Fung, H. B. Clinical Therapeutics 2008, 29, 1862-1886.
  • 16. Ashok, M.; Holla, B. S.; Poojary, B. Eur. J. Med. Chem. 2007, 42, 1095-1101.
  • 17. Rao, B. M.; Sangaraju, S.; Srinivasu, M. K.; Madhavan, P.; Devi, M. L.; Kumar, P. R.; Candrasekhar, K. B.; Arpitha, C.; Balaji, T. S. J. Pharm. Biomed. Anal. 2006, 41, 1146-1151.
  • 18. Hancu, G.; Gaspar, A.; Gyeresi, A.; J. Biochem. Biophys. Methods 2007, 69, 251-259.
  • 19. Bajetti, E.; Zilembo, N.; Bichisao, E.; Pozzi, P.; Toffolatti, L.Critical Reviews in Oncology:Hematolog 2000, 33, 137-142.
  • 20. Demirbas, A.; Ceylan, S.; Demirbas, N. J. Het. Chem. 2007, 44, 1271-1280.
  • 21. Foulon, C.; Danel, C.; Vaccher, C.; Yous, S.; Bonte, J. P.; Goossens, J. F.; J. Chromatographi A. 2004, 1035, 131-136.
  • 22. Almajan, G. L.; Innocenti, A.; Puccetti, L.; Manole, G.; Barbuceanu, S.; Saramet, I.; Scozzafava, A.; Supuran, C. T. Bioorg Med. Chem. Lett. 2005, 15, 2347-2352.
  • 23. Palaska, E.; Şahin, G.; Kelicen, P.; Durlu, N. T.; Altinok, G. Il Farmaco 2002, 57, 101-107.
  • 24. Karakuş, S.; Rollas, S. Il Farmaco 2002, 57, 577-581.
  • 25. Temperini, C.; Cecchi, A.; Scozzafava, A.; Supuran, C. T. Bioorg. Med. Chem. 2009 in press.
  • 26. Castle, S. S.; Comprehensive Pharm. Ref. 2008, 1-5.
  • 27. Crucq, A. S.; Slegers, C.; Deridder, V.; Tilquin, B. Talanta 2000, 52, 873-877.
  • 28. Fujimura, S.; Sato, T.; Mikami, T.; Kikuchi, T.; Gami, K.; Watanabe, A. Int. J. Antimic. Agents. 2008, 32, 481-484.
  • 29. Demirbas, N.; Demirbas, A.; Alpay-Karaoğlu, S.; Çelik, E. Arkıvoc 2005, (i), 75-91.
  • 30. İkizler, A.; Demirbaş, N.; İkizler, A. A. J. Het. Chem. 1996, 33, 1765-1769.
  • 31. İkizler, A.; Demirbaş, N., Demirba¸s, A.; İkizler, A. A. Polish J., Chem. 1996, 70, 1114-1120.
  • 32. İkizler, A. A.; Uçar, F.; Demirba¸s, N.; Yasa, ˙I.; Demirba¸s, A.; Genzer, T. Indian J. Pharm. Sci. 1999, 61, 271-274.
  • 33. Bayrak, H.; Demirbas, A.; Demirbas, N.; Alpay-Karaoglu, S.; Eur. J. Med. Chem. 2009, in press.
  • 34. National Committee for Clinical Laboratory Standard, NCCLS Document M7-A3, 13, (25), Villanova, PA., USA, 1993.
  • 35. Milcent, R.; Redeuilh, C. J. Het. Chem. 1979, 16, 403-407.
  • 36. Mamolo, M. G.; Falagiani, V.; Zampieri, D.; Vio, L.; Banfi, E. Il Farmaco 2001, 56, 587-592.
  • 37. Galic, N.; Peric, B.; Kojic-Prodic, B.; Cimerman, Z. J. Mol. Stuc. 2001, 559, 187-194.
  • 38. Wyrzykiewicz, E.; Prukah,D. J. Het. Chem. 1998, 35, 381-387.
  • 39. Foroumadi, A., Mirzai, M.; Shafiee, A. Il Farmaco 2001, 56, 621-623.
  • 40. Ulusoy, N.; Gürsoy, A.; Ötük, G. Il Farmaco 2001, 56, 947-952.
  • 41. Collin, X.; Sauleau, A.; Coulon, J. Bioorg. Med. Chem. 2003, 13, 2601-2605.
  • 42. Karakuş, S.; Rollas, S. Il Farmaco 2002, 5, 577-581.
  • 43. Varvaresou, A., Siatra-Papastaikoudi, T.; Tsotinis, A.; Tsantili-Kakoulidou, A.; Vamvakides, A. Il Farmaco 1998, 53, 320-326.
  • 44. Demirbas, A.; Sahin, D.; Demirbas, N.; Alpay-Karaoglu, S. Eur. J. Med. Chem. 2009, 44, 2896-2903.
APA BEKTAŞ H, DEMİRBAŞ A, DEMİRBAŞ N, BAYRAK H, Alpay Karaoğlu Ş (2010). Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties. , 517 - 527.
Chicago BEKTAŞ Hakan,DEMİRBAŞ Ahmet,DEMİRBAŞ NESLİHAN,BAYRAK Hacer,Alpay Karaoğlu Şengül Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties. (2010): 517 - 527.
MLA BEKTAŞ Hakan,DEMİRBAŞ Ahmet,DEMİRBAŞ NESLİHAN,BAYRAK Hacer,Alpay Karaoğlu Şengül Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties. , 2010, ss.517 - 527.
AMA BEKTAŞ H,DEMİRBAŞ A,DEMİRBAŞ N,BAYRAK H,Alpay Karaoğlu Ş Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties. . 2010; 517 - 527.
Vancouver BEKTAŞ H,DEMİRBAŞ A,DEMİRBAŞ N,BAYRAK H,Alpay Karaoğlu Ş Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties. . 2010; 517 - 527.
IEEE BEKTAŞ H,DEMİRBAŞ A,DEMİRBAŞ N,BAYRAK H,Alpay Karaoğlu Ş "Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties." , ss.517 - 527, 2010.
ISNAD BEKTAŞ, Hakan vd. "Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties". (2010), 517-527.
APA BEKTAŞ H, DEMİRBAŞ A, DEMİRBAŞ N, BAYRAK H, Alpay Karaoğlu Ş (2010). Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties. Turkish Journal of Chemistry, 34(4), 517 - 527.
Chicago BEKTAŞ Hakan,DEMİRBAŞ Ahmet,DEMİRBAŞ NESLİHAN,BAYRAK Hacer,Alpay Karaoğlu Şengül Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties. Turkish Journal of Chemistry 34, no.4 (2010): 517 - 527.
MLA BEKTAŞ Hakan,DEMİRBAŞ Ahmet,DEMİRBAŞ NESLİHAN,BAYRAK Hacer,Alpay Karaoğlu Şengül Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties. Turkish Journal of Chemistry, vol.34, no.4, 2010, ss.517 - 527.
AMA BEKTAŞ H,DEMİRBAŞ A,DEMİRBAŞ N,BAYRAK H,Alpay Karaoğlu Ş Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties. Turkish Journal of Chemistry. 2010; 34(4): 517 - 527.
Vancouver BEKTAŞ H,DEMİRBAŞ A,DEMİRBAŞ N,BAYRAK H,Alpay Karaoğlu Ş Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties. Turkish Journal of Chemistry. 2010; 34(4): 517 - 527.
IEEE BEKTAŞ H,DEMİRBAŞ A,DEMİRBAŞ N,BAYRAK H,Alpay Karaoğlu Ş "Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties." Turkish Journal of Chemistry, 34, ss.517 - 527, 2010.
ISNAD BEKTAŞ, Hakan vd. "Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties". Turkish Journal of Chemistry 34/4 (2010), 517-527.